Biomarkers for Cystic Fibrosis Drug Development

PURPOSE: To provide a review of the status of biomarkers in cystic fibrosis drug development, including regulatory definitions and considerations, a summary of biomarkers in current use with supportive data, current gaps, and future needs. METHODS: Biomarkers are considered across several areas of C...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Cyst Fibros
Prif Awduron: Muhlebach, Marianne S., Clancy, JP, Heltshe, Sonya L., Ziady, Assem, Kelley, Tom, Accurso, Frank, Pilewski, Joseph, Mayer-Hamblett, Nicole, Joseloff, Elizabeth, Sagel, Scott D.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2016
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5321565/
https://ncbi.nlm.nih.gov/pubmed/28215711
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcf.2016.10.009
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg